EFFICIENCY OF APPLICATION OF RIBOMUNYL FOR CHILDREN WITH PERSISTENT ASTHMA

The control efficiency of the symptoms of the bronchial asthma (BA) by children is defined in many respects by the phenotypic characteristics and features of an inflammation. The infectious factor is the main factor in genesis of BA by the majority of children of the preschool, and sometimes of school age. The recurrent respiratory tracts diseases, the exacerbation of the chronical focus of nasopharyngeal infection result in the inadequacy of basic therapy, main-tain bronchial hyperresponsiveness. The prescription of ribosome vaccine (ribomunyl) for children with persistent asthma depending on an infectious factor, for 6-month course led to reduction of quantity of the exacerbations, caused by respiratory infections, to the reduction of a bacterial content of mucous membrane, to the positive changes of the nonspecific immunity, that improves the controllability of asthma.